Will cannabis be fully legalized under Trump's second term?

Full federal legalization via a sweeping bill is highly unlikely. The focus will be on narrower, business-oriented reforms like the SAFE Banking Act and the administrative rescheduling of cannabis from Schedule I to Schedule III by the DEA.

What is the SAFE Banking Act and why does it matter?

The SAFE Banking Act is a bill that would allow state-legal cannabis businesses to access traditional banking, loans, and financial services. It matters because it would end the dangerous, all-cash economy, reduce security risks, and unlock investment needed for the industry to grow and stabilize.

How would rescheduling to Schedule III help the cannabis industry?

Moving cannabis to Schedule III would remove the crippling IRS code 280E, which currently prohibits state-legal cannabis businesses from deducting standard business expenses like rent, payroll, and marketing. This would instantly improve profitability and allow companies to reinvest in their operations.

Should social equity efforts in cannabis continue without federal support?

Absolutely. While federal momentum for equity may stall, state and local programs remain crucial. Furthermore, industry leaders and consumers have a responsibility to support businesses owned by those impacted by prohibition and advocate for fair licensing and expungement at every level of government.

Cannabis Industry Trump 2026: A Surprising Outlook

The political winds have shifted again, and the smoke is clearing to reveal a landscape the cannabis industry didn’t fully expect. With Donald Trump’s return to the White House in 2025, many advocates braced for a regulatory deep freeze. But talk to CEOs, lobbyists, and analysts now in early 2026, and you’ll find a nuanced, even cautiously optimistic, outlook on the next four years. The driving force? A potent blend of undeniable state-level momentum, a Republican party increasingly listening to its business-minded wing, and a simple political calculation: the federal prohibition of cannabis is now a liability, not a winner, for most politicians. This unique moment is shaping the cannabis industry Trump 2026 strategy in fascinating ways.

From Skepticism to Strategic Hope

Let’s be real—the industry’s initial reaction to the 2024 election results was a collective gulp. Memories of former Attorney General Jeff Sessions haunt this community. Yet, the ground has fundamentally moved since 2018. 38 states have legalized medical cannabis, and 24 have legalized adult use, including conservative strongholds like Ohio, Florida (via ballot initiative), and Montana. The genie isn’t just out of the bottle; it’s paying taxes and employing hundreds of thousands. This creates immense pressure no administration can ignore.

The GOP's Evolving Stance on States' Rights

The most significant change is within the Republican party itself. The old-school “law and order” prohibitionists are being drowned out by a powerful coalition of libertarians and business conservatives. For them, the patchwork of conflicting state and federal laws is a regulatory nightmare that stifles entrepreneurship. Key figures like Senate Majority Leader John Thune (R-SD) and House Speaker Steve Scalise (R-LA) have publicly shifted toward supporting states' rights frameworks. The SAFE Banking Act, which would grant cannabis businesses access to financial services, has repeatedly passed the House with bipartisan support and now has its strongest-ever GOP backing in the Senate. The argument is no longer about weed; it’s about allowing legal businesses in states like Arizona and Missouri to operate safely and bank their profits.

The Trump Administration's Likely Playbook

So, what can the industry realistically expect? Full federal legalization via a Democratic-style sweeping bill is off the table. Instead, the path forward under this administration will be narrower, driven by commerce and public safety concerns rather than social justice.

Priority One: SAFE Banking and Capital

The single most likely achievement in 2026 or 2027 is the passage of the SAFE Banking Act. The White House has signaled it would not stand in the way. This is the top priority for multi-state operators (MSOs) drowning in cash-only burdens and security risks. Unlocking traditional banking and lending would trigger a wave of institutional investment and consolidation, allowing the industry to mature financially. It’s a “business fix” this administration can get behind.

Rescheduling: A Quiet Bureaucratic Win

Another area of quiet optimism lies with the Drug Enforcement Administration (DEA). Following the 2022 HHS recommendation, the DEA is expected to finally announce its decision on rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act. This administrative action, started under Biden, is likely to be completed under Trump. While not legalization, Schedule III status would be a seismic shift, removing the crushing 280E tax code that prevents businesses from deducting standard expenses, instantly making profitable companies like those behind the famous Gorilla Glue #4 strain more viable.

The Wild Cards and Remaining Risks

Of course, optimism is tempered with vigilance. The industry’s growth still faces potential headwinds.

The HHS & FDA Regulatory Hammer

Moving to Schedule III places cannabis under more direct Food and Drug Administration (FDA) oversight for therapeutic claims. This could lead to a crackdown on product marketing, especially for edibles and extracts that might appeal to youth. Companies that have invested in robust compliance, like many of our trusted partners at North Atlantic Seed Co., will be better positioned, but others may face stiff new regulations.

Social Equity on the Backburner

The biggest casualty of a business-first approach is likely to be federal social equity programs. Expungement of records and targeted support for communities disproportionately harmed by the War on Drugs were centerpieces of Democratic proposals. These issues are not a priority for the current GOP leadership, meaning the hard work will remain at the state level. The industry must continue to self-police and invest in equity, even without a federal mandate.

What This Means For You

Whether you’re a patient, a casual consumer, or an aspiring cultivator, this political shift has real-world implications. For consumers, the primary benefit will be industry stabilization. SAFE Banking means more secure, sophisticated retail experiences and potentially more investment in quality control and R&D—imagine even more consistent and innovative strains like Apple Fritter. For home growers, federal rescheduling could slowly normalize cannabis, reducing stigma and possibly easing restrictions on cloning and seed genetics over the long term.

Most importantly, the center of gravity for cannabis reform has permanently shifted to the states. The fight for home grow rights, social consumption lounges, and market structure will be won or lost in your state capital. The federal government appears poised to finally stop being the primary obstacle and start becoming a (reluctant) facilitator of the existing legal market. That’s not the green wave many hoped for, but in the pragmatic world of cannabis business, it’s a foundation to build upon. Keep your eyes on Congress and the DEA this year—the moves they make will set the tone for the next decade of the industry.

Weed Industry Outlook on Trump's Second Term